Apellis Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share (APLS)

Q: What does CUSIP 03753U106 represent in this 13F holders report?

CUSIP 03753U106 is the security identifier for APLS - Apellis Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share used to aggregate holder disclosures.

Q: How many institutions held APLS - Apellis Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share in Q2 2018?

73 institutional investors reported APLS - Apellis Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share for Q2 2018. Use the holders table for investor-level position and value details.

CUSIP: 03753U106

Q2 2018 13F Holders as of 30 Jun 2018

Type / Class: Equity / Common Stock, $0.0001 par value per share
Shares outstanding: 127,672,507
Total 13F shares: 29,064,186
Share change: +12,025,367
Total reported value: $639,413,620
Price per share: $22.00
Number of holders: 73
Value change: +$265,705,567
Number of buys: 66
Number of sells: 11

Security key

03753U106

Report period

Q2 2018

Institutions

Top holders

APLS full security history Newer quarter: Q3 2018 Previous quarter: Q1 2018 Apellis Pharmaceuticals, Inc. SEC filings Apellis Pharmaceuticals, Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Reporting periods

Holder history for CUSIP 03753U106

Newer quarter: Q3 2018 Previous quarter: Q1 2018

Recent filing periods:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of APLS - Apellis Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
Cormorant Asset Management, LP	13F	Company	3.2%	4,088,229	$90,390,000	—	31 Mar 2018	13F
SECTORAL ASSET MANAGEMENT INC	13F	Company	1.3%	1,647,692	$36,430,000	—	31 Mar 2018	13F
Vivo Capital, LLC	13F	Company	1.1%	1,457,834	$32,233,000	—	31 Mar 2018	13F
HILLHOUSE INVESTMENT MANAGEMENT, LTD.	13F	Company	1.1%	1,428,571	$31,586,000	—	31 Mar 2018	13F
BlackRock Finance, Inc.	13F	Company	0.87%	1,106,847	$24,473,000	—	31 Mar 2018	13F
EcoR1 Capital, LLC	13F	Company	0.83%	1,056,348	$23,356,000	—	31 Mar 2018	13F
FMR LLC	13F	Company	0.78%	997,764	$22,061,000	—	31 Mar 2018	13F
Sofinnova Investments, Inc.	13F	Company	0.71%	911,752	$20,159,000	—	31 Mar 2018	13F
RA CAPITAL MANAGEMENT, L.P.	13F	Company	0.7%	900,000	$19,899,000	—	31 Mar 2018	13F
CLOUGH CAPITAL PARTNERS L P	13F	Company	0.49%	621,616	$13,673,000	—	31 Mar 2018	13F
Avoro Capital Advisors LLC	13F	Company	0.31%	396,635	$7,454,000	—	31 Mar 2018	13F
VANGUARD GROUP INC	13F	Company	0.3%	382,653	$8,461,000	—	31 Mar 2018	13F
JENNISON ASSOCIATES LLC	13F	Company	0.3%	379,151	$8,383,000	—	31 Mar 2018	13F
VICTORY CAPITAL MANAGEMENT INC	13F	Company	0.29%	372,840	$8,243,000	—	31 Mar 2018	13F
NF Trinity Capital (Hong Kong) Ltd	13F	Company	0.28%	357,142	$7,896,000	—	31 Mar 2018	13F
STATE STREET CORP	13F	Company	0.13%	170,946	$3,778,000	—	31 Mar 2018	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.12%	149,992	$3,316,000	—	31 Mar 2018	13F
S.c.a. Candriam	13F	Individual	0.1%	124,000	$2,742,000	—	31 Mar 2018	13F
NORTHERN TRUST CORP	13F	Company	0.09%	119,443	$2,640,000	—	31 Mar 2018	13F
NORGES BANK	13F	Company	0.06%	75,000	$1,658,000	—	31 Mar 2018	13F
Russell Investments Group, Ltd.	13F	Company	0.04%	50,054	$1,107,000	—	31 Mar 2018	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.03%	42,691	$944,000	—	31 Mar 2018	13F
Bank of New York Mellon Corp	13F	Company	0.03%	34,887	$771,000	—	31 Mar 2018	13F
MORGAN STANLEY	13F	Company	0.02%	20,502	$453,000	—	31 Mar 2018	13F
TIAA CREF INVESTMENT MANAGEMENT LLC	13F	Company	0.02%	19,289	$426,000	—	31 Mar 2018	13F
TEACHERS ADVISORS, LLC	13F	Company	0.01%	17,311	$383,000	—	31 Mar 2018	13F
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM	13F	Company	0.01%	16,727	$370,000	—	31 Mar 2018	13F
DEUTSCHE BANK AG\	13F	Company	0.01%	14,384	$317,000	—	31 Mar 2018	13F
NEW YORK STATE COMMON RETIREMENT FUND	13F	Company	0.01%	11,100	$245,000	—	31 Mar 2018	13F
MANUFACTURERS LIFE INSURANCE COMPANY, THE	13F	Company	0.01%	9,602	$213,000	—	31 Mar 2018	13F
RHUMBLINE ADVISERS	13F	Company	0.01%	9,307	$206,000	—	31 Mar 2018	13F
AMERICAN INTERNATIONAL GROUP, INC.	13F	Company	0.01%	7,071	$156,000	—	31 Mar 2018	13F
WELLS FARGO & COMPANY/MN	13F	Company	0%	6,149	$136,000	—	31 Mar 2018	13F
MetLife Investment Management, LLC	13F	Company	0%	5,716	$126,000	—	31 Mar 2018	13F
UBS Group AG	13F	Company	0%	5,191	$115,000	—	31 Mar 2018	13F
DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main	13F	Company	0%	4,208	$93,000	—	31 Mar 2018	13F
METROPOLITAN LIFE INSURANCE CO/NY	13F	Company	0%	4,020	$88,882	—	31 Mar 2018	13F
STRS OHIO	13F	Company	0%	3,100	$68,000	—	31 Mar 2018	13F
FEDERATED HERMES, INC.	13F	Company	0%	3,044	$67,000	—	31 Mar 2018	13F
BARCLAYS PLC	13F	Company	0%	2,367	$53,000	—	31 Mar 2018	13F
JPMORGAN CHASE & CO	13F	Company	0%	2,227	$49,000	—	31 Mar 2018	13F
BNP PARIBAS FINANCIAL MARKETS	13F	Company	0%	1,955	$43,225	—	31 Mar 2018	13F
Legal & General Group Plc	13F	Company	0%	1,882	$42,000	—	31 Mar 2018	13F
BANK OF AMERICA CORP /DE/	13F	Company	0%	1,028	$23,000	—	31 Mar 2018	13F
Ameritas Investment Partners, Inc.	13F	Company	0%	920	$20,000	—	31 Mar 2018	13F
Tower Research Capital LLC (TRC)	13F	Company	0%	405	$9,000	—	31 Mar 2018	13F

Institutional Holders of Apellis Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share (APLS) as of Q2 2018

As of 30 Jun 2018, Apellis Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share (APLS) was held by 73 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 29,064,186 shares. The largest 10 holders included Hillhouse Capital Management, Ltd., Cormorant Asset Management, LP, BlackRock Inc., Sectoral Asset Management Inc, Vivo Capital, LLC, FMR LLC, VANGUARD GROUP INC, STATE STREET CORP, PRICE T ROWE ASSOCIATES INC /MD/, and VICTORY CAPITAL MANAGEMENT INC. This page lists 73 institutional shareholders reporting positions in this security for the Q2 2018 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2018 vs Q1 2018 Across Filers

Q1 2018 holders

Q2 2018 holders

Holder diff

Investor	Q1 2018 Shares	Q2 2018 Shares	Share Diff	Share Chg %	Q1 2018 Value $	Q2 2018 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.